T. Baykal

598 citations
18 papers · 449 indexed · h-index 14
Topics
Metabolism and Genetic Disorders (11 papers)Neonatal Health and Biochemistry (6 papers)Biotin and Related Studies (6 papers)
Journals
SHILAP Revista de lepidopterologíaHuman MutationHuman Genetics

In The Last Decade

T. Baykal

18 papers receiving 438 citations

Peers

T. Baykal
Comparison fields: 5 of 56
  • Clinical Biochemistry 237
  • Molecular Biology 228
  • Cell Biology 135
  • Organic Chemistry 115
  • Rheumatology 88
Replace R. Baumgartner with:
R. Baumgartner Switzerland
S Scheibenreiter Austria
Maria Luı́s Cardoso Portugal
D. Leupold Germany
H. Niederhoff Germany
Mercedes Martínez‐Pardo Spain
F. Šmíd Czechia
H. D. Bakker Netherlands
I. Hargreaves United Kingdom
M. Blaskovics United States
T. Baykal relative to R. Baumgartner Switzerland R. Baumgartner's profile →
Citations per field
00.5×4.4×
R. Baumgartner · 1×
Citations per year

Countries citing papers authored by T. Baykal

Since Specialization
Citations

This map shows the geographic impact of T. Baykal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Baykal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Baykal more than expected).

Fields of papers citing papers by T. Baykal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Baykal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Baykal. The network helps show where T. Baykal may publish in the future.

Co-authorship network of co-authors of T. Baykal

This figure shows the co-authorship network connecting the top 25 collaborators of T. Baykal. A scholar is included among the top collaborators of T. Baykal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Baykal. T. Baykal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 71
2 20
3 14
4 32
5 30
6 37
7 7
8 19
9
Type II hyperprolinemia: a case report.
13
10 20
11 10
12 46
13 15
14 31
15 16
16 39
17 19
18 10

About T. Baykal

T. Baykal is a scholar working on Clinical Biochemistry, Cell Biology and Pediatrics, Perinatology and Child Health, having authored 18 papers that have together received 449 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (11 papers), Neonatal Health and Biochemistry (6 papers) and Biotin and Related Studies (6 papers). The work is most often cited by research in Clinical Biochemistry (237 citations), Cell Biology (135 citations) and Rheumatology (88 citations). T. Baykal has collaborated with scholars based in Türkiye, United States and Switzerland. Frequent co-authors include Mübeccel Demirkol, Gülden Gökçay, Barry Wolf, Yasemi̇n Gökdemi̇r, Beat Thöny, Nenad Blau, Kevin P. Jensen, Ferhat Demir, Fatih Demir and Ertan Mayatepek. Their work appears in journals such as SHILAP Revista de lepidopterología, Human Mutation and Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026